News
Deals and Financings Suzhou MediLink Therapeutics out-licensed global rights (ex-China) for its antibody-drug conjugate candidate against Human Epidermal Growth Factor Receptor 3 (HER3) to...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Roberts Berzins has over a decade of experience in the financial management helping top-tier corporates shape their financial...
News
This article was written by Follow Raymond James Investment Management is a global asset management company that combines the exceptional insight and agility of...
News
This article was written by Follow I am focused on growth and dividend income. My personal strategy revolves around setting myself up for an...
News
If the fourth quarter stock market rally doesn’t come in 2023, blame the bond market. This past trading week offers a good example of...
News
Assertio Holdings (NASDAQ:ASRT) stands at a pivotal juncture in its history. A mere 3.5 years ago, Assertio’s portfolio was heavily reliant on ZIPSOR and...
News
By Peter Bourbeau and Margaret Vitrano Moving to the Middle as Growth Slows Market Overview Equities took a breather in the third quarter, pressured...
News
After Coke (KO) and Pepsi (PEP), Keurig Dr Pepper (NASDAQ:KDP) is the third-largest beverage company in North America, with annual revenues of approximately $14...
News
By Robert Feitler and Dmitry Khaykin Risk Mitigation Is the Other Half of Upside Participation Market Overview U.S. equities pulled back from highs reached...
News
Focused on the Fundamentals In a recent Management Meeting, PayPal (NASDAQ:PYPL) executives went into details on some key business initiatives that they are rolling...
News
The Oakmark Global Fund (MUTF:OAKGX, the “Fund”) returned 26.88% for the fiscal year ended September 30, 2023, outperforming its benchmark, the MSCI World Index...
News
The Oakmark Global Select Fund (OAKWX, the “Fund”) returned 27.70% for the fiscal year ended September 30, 2023, outperforming the MSCI World Index (net),...
News
The Oakmark International Fund (MUTF:OAKIX, “the Fund”) increased 34.39% for the fiscal year ended September 30, 2023, outperforming the benchmark, the MSCI World ex...
